Skip to main content
SpringerLink
Log in

Reducing Medication Errors Through Naming, Labeling, and Packaging

  • Published:
Journal of Medical Systems Aims and scope Submit manuscript

Abstract

Errors due to look-alike or sound-alike medication names are common in the United States, and are responsible for thousands of deaths and millions of dollars in cost each year. Up to 25% of all medication errors are attributed to name confusion, and 33% to packaging and/or labeling confusion. Thousands of medication name pairs have been confused based on similar appearances or sounds when written or spoken, or have been identified as having the potential for confusion. Systems and recommendations have been developed that may reduce the occurrence of such errors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Brennan, T. A., Leape, L. L., Laird, N. M., Hebert, L., Localio, A. R., Lawthers, A. G., Newhouse, J. P., Weiler, P. C., and Hiatt, H., Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N. Engl. J. Med. 324(6):370–376, 1991.

    Google Scholar 

  2. Thomas, E. J., Studdert, D. M., Burstin, H. R., Orav, E. J., Zeena, T., Williams, E. J., Howard, K. M., Weiler, P. C., and Brennan, T. A., Incidence and types of adverse events and negligent care in Utah and Colorado. Med. Care. 38(3):261–271, 2000.

    Google Scholar 

  3. Bates, D. W., Cullen, D. J., Laird, N., Petersen, L. A., Small, S. D., Servi, D., Laffel, G., Sweitzer, B. J., Shea, B. F., Hallisey, R., Vander Vliet, M., Nemeskal, R., and Leape, L. L.; for the ADE Prevention Study Group. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 274(1):29–34, 1995.

    Google Scholar 

  4. Leape, L. L., Brennan, T. A., Laird, N., Lawthers, A. G., Localio, A. R., Barnes, B. A., Hebert, L., Newhouse, J. P., Weiler, P. C., and Hiatt, H., The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N. Engl. J. Med. 324(6):377–384, 1991.

    Google Scholar 

  5. Institute of Medicine, To Err Is Human, Full text available at http://www.nap.edu/books/0309068371/html/.

  6. Bates, D. W., Spell, N., Cullen, D. J., Burdick, E., Laird, N., Petersen, L. A., Small, S. D., Sweitzer, B. J., and Leape, L. L., The costs of adverse drug events in hospitalized patients. JAMA 277(4):307–311, 1997.

    Google Scholar 

  7. Schneider, P. J., Gift, M. G., Lee, Y. P., Rothermich, E. A., and Sill, B. E., Cost of medication-related problems at a university hospital. Am. J. Health Syst. Pharm. 52(21):2415–2418, 1995.

    Google Scholar 

  8. Lazarou, J., Pomeranz, B. H., and Corey, P. N., Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 279(15):1200–1205, 1998.

    Google Scholar 

  9. Chyka, P. A., How many deaths occur annually from adverse drug reactions in the United States? Am. J. Med. 109(2):122–130, 2000.

    Google Scholar 

  10. Phillips, D. P., Christenfeld, N., and Glynn, L. M., Increase in US medication-error deaths between 1983 and 1993. Lancet 351(9103):643–644, 1998.

    Google Scholar 

  11. Aiming at Administering: Practice Recommendations to Prevent Errors. USP Quality Review No. 71, January 2000. Available at http://www.usp.org/reporting/review/qr71.pdf.

  12. Leape, L. L., Bates, D. W., Cullen, D. J., Cooper, J., Demonaco, H. J., Gallivan, T., Hallisey, R., Ives, J., Laird, N., Laffel, G., Nemeskal, R., Petersen, L. A., Porter, K., Servi, D., Shea, B. F., Small, S. D., Sweitzer, B. J., Thompson, B. T., and Vander Vliet, M.: for the ADE Prevention Study Group. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 274(1):35–43, 1995.

    Google Scholar 

  13. Lesar, T. S., Briceland, L., and Stein, D. S., Factors related to errors in medication prescribing. JAMA 277(4):312–317, 1997.

    Google Scholar 

  14. Stop, Look and Listen! USP Quality Review No. 49, July 1995. Available at www.usp.org.

  15. For Regulators and Standard-Setters. USP Quality Review No. 62, May 1998. Available at www.usp.org/reporting/review/rev_062f.htm.

  16. Lambert, B. L., Predicting look-alike and sound-alike medication errors. Am. J. Health Sys. Pharm. 54(10):1161–1171, 1997.

    Google Scholar 

  17. USAN Stem List. Available at http://www.ama-assn.org/ama1/pub/upload/mm/365/usanstemlist_021003.doc.

  18. Three Is a Crowd... USP Quality Review No. 68. September 1999. Available at http://www.usp.org/reporting/review/qr68.pdf.

  19. Amrinone Becomes Inamrinone. USP Quality Review No. 73, March 2000. Available at http://www.usp.org/reporting/review/qr73.pdf.

  20. Kenagy, J. W., and Stein, G. C., Naming, labeling, and packaging of pharmaceuticals. Am. J. Health Syst. Pharm. 58:2033–2041, 2001.

    Google Scholar 

  21. Use Caution, Avoid Confusion. USP Quality Review No. 76, March 2001. Available at http://www.usp.org/reporting/review/qr76.pdf.

  22. Billups, N. F., and Billups, S. M. (eds.), American Drug Index (46th ed.) Kluwer, St. Louis, MN, 2002.

    Google Scholar 

  23. Lambert, B. L., Lin, S. J., Chang, K. Y., and Gandhi, S. K., Similarity as a risk factor in drug-name confusion errors: The look-alike (orthographic) and sound-alike (phonetic) model. Med. Care 37(12):1214–1225, 1999.

    Google Scholar 

  24. ISMP Medication Safety Alert, Vol. 7,No. 7, April 3, 2002.

    Google Scholar 

  25. Schwab, M., Oetzel, C., Mörike, K., Jägle, C., Gleiter, C. H., and Eichelbaum, M., Using trade names as a risk factor for accidental drug overdose. Arch. Intern. Med. 1065–1066, 2002.

  26. Cohen, M. R., Trade names, INNs, and medication errors. Arch. Intern. Med. 162(22):2636, 2002.

    Google Scholar 

  27. Product Content Confusion. USP Quality Review No. 54, May 1996. Available at http://www.usp.org/reporting/review/rev_054b.htm.

  28. Unintentional Acetaminophen Overdosing. USP Quality Review No. 54, May 1996. Available at http://www.usp.org/reporting/review/rev_054c.htm.

  29. “Verapamil” in Clinical Pharmacology Section of Physicians Online. Available at www.pol.net (physicians only).

  30. ISMP Medication Safety Alert, Vol. 7,No. 12, June 12, 2002.

    Google Scholar 

  31. ISMP Medication Safety Alert, Vol. 7,No. 14, July 10, 2002.

    Google Scholar 

  32. ISMP Medication Safety Alert, Vol. 7,No. 17, August 21, 2002.

    Google Scholar 

  33. Rajski, M. J., Medication naming, labeling, and packaging. Am. J. Health Syst. Pharm. 59(9):877, 2002.

    Google Scholar 

  34. ISMP Medication Safety Alert, Vol. 7,No. 2, January 23, 2002.

    Google Scholar 

  35. Mitka, M., What's in a (drug) name? Plenty! JAMA 282(15):1409–1410, 1999.

    Google Scholar 

  36. Look-Alike, Sound-Alike Drug Names. JCAHO Sentinel Event Alert No. 19, May 2001. Available at www.jcaho.org/about+us/news+letters/sentinel+event+alert/sea_19.htm.

  37. FDA Name Differentiation Project. Available at http://www.ismp.org/msaarticles/drugnames.html.

  38. Symonds, J. K., and Robertson, W. O., Drug identification: Use of coded imprint. JAMA 199:158–160, 1967.

    Google Scholar 

  39. Vasudevan, P., Del Gianni, T., and Robertson, W. O., Avoiding medication mixups. Identifiable imprint codes. West. J. Med. 165(6):352–354. 1996. Abstract available via Medline.

    Google Scholar 

  40. FDA Proposes Drug Bar Code Regulation. FDA News, March 13, 2003. Available at http://www.fda.gov/oc/initiatives/barcode-sadr/fs-barcode.html.

  41. Young, D., Health care industry informs FDA of bar-code needs. Am. J. Health Syst. Pharm. 59(17):1592, 2002.

    Google Scholar 

  42. Policy Statement: Color Codes for Topical Ocular Medications. American Academy of Ophthalmology, February 2000. Available at www.aao.org/aao/member/policy/color.cfm.

  43. Radhakrishna, S., Syringe labels in anaesthetic induction rooms. Anaesthesia 54(10):963–968, 1999.

    Google Scholar 

  44. Cohen, M. R., Medication naming, labeling and packaging. Am. J. Health Syst. Pharm. 59(9):876–877, 2002.

    Google Scholar 

  45. ISMP Medication Safety Alert, Vol. 8,No. 1, January 9, 2003.

    Google Scholar 

  46. Ophthalmic Products Similar Packaging/Labeling Initiates Changes. Practioners' Reporting News, May 8, 2002. Available via www.usp.org.

  47. It Doesn't Pay to Play the Percentages. ISMP Medication Safety Alert, Vol. 7,No. 21, 2002.

  48. Medication Error Related to Potentially Dangerous Abbreviations. JCAHO Sentinel Event Alert No. 23, September 2001. vailable at http://www.jcaho.org/ about+us/news+letters/sentinel+event+alert/sea_23.htm.

  49. ISMP Medication Safety Alert, Vol. 7,No. 22, 2002.

    Google Scholar 

  50. Wheeler, J., and Shah, P., Reviews: Minerva. BMJ 322:182, 2002.

    Google Scholar 

  51. Safety Briefs. ISMP Medication Safety Alert, Vol. 7,No. 16, 2002.

  52. Robertson, S. O., Alphabet soup. JAMA 244:1902, 1980.

    Google Scholar 

  53. Do Not Use These Dangerous Abbreviations or Dose Designations. Special Issue. Institute for Safe Medical Practices. Available at http://www.ismp.org/msaarticles/specialissuetableprint.htm and http://www.ismp.org/msaarticles/specialissuetable.html

  54. Bates, D. W., Leape, L. L., Cullen, D. J., Laird, N., Petersen, L. A., Teich, J. M., Burdick, E., Hickey, M., Kleefield, S., Shea, B., Vander Vliet, M., and Seger, D. L., Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 280(15):1311–1316, 1998.

    Google Scholar 

  55. Safety Briefs. ISMP Medication Safety Alert, Vol. 7,No. 8, April 17, 2002.

  56. Meyer, T. A., Improving the quality of the order-writing process for inpatient orders and outpatient prescriptions. Am. J. Health Syst. Pharm. 57(Suppl. 4):S18–S22, 2000.

    Google Scholar 

  57. Anonymous. A study of physicians' handwriting as a time waster. JAMA 242:2429–2430, 1979.

  58. Recommendations for Prescription Writing. USP Quality Review No. 57, January 1997. Available at www.usp.org.

  59. Dean, B. S., Allan, E. L., Barber, N. D., and Barker, K. N., Comparison of medication errors in an American and a British hospital. Am. J. Health Syst. Pharm. 52(22):2543–2549, 1995.

    Google Scholar 

  60. Cohen, M. R., Understanding and preventing drug misadventures: Drug product characteristics that foster drug-use-system errors. Am. J. Health Syst. Pharm. 52(4):395–399, 1995.

    Google Scholar 

  61. Safety Briefs. ISMP Medication Safety Alert, Vol. 7,No. 9, May 1, 2002.

  62. Phillips, J., Beam, S., Brinker, A., Holquist, C., Honig, P., Lee, L., Parner, C. Retrospective analysis of mortalities associated with medication errors. Am. J. Health Sys. Pharm. 58(19):1835–1841, 2001.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health Policy and Administration, School of Public Health, University of Illinois at Chicago, Chicago, Illinois

    Adrienne Berman

Authors
  1. Adrienne Berman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adrienne Berman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berman, A. Reducing Medication Errors Through Naming, Labeling, and Packaging. Journal of Medical Systems 28, 9–29 (2004). https://doi.org/10.1023/B:JOMS.0000021518.60670.10

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:JOMS.0000021518.60670.10

Search

Navigation